Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
about
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceOncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosisHelminth infections: the great neglected tropical diseasesBiological Treatments in Atopic DermatitisThe involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitisDeciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesSTAT6-dependent and -independent mechanisms in Th2 polarizationNew era of biologic therapeutics in atopic dermatitisTreatment of allergic asthma: modulation of Th2 cells and their responsesChemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosisRosacea: The cytokine and chemokine networkNew insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?Basic mechanisms of itch.Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseasesIL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infectionNeural processing of itch.The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 inductionRecent insights into atopic dermatitis and implications for management of infectious complications.Associations between Interleukin-31 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Population.Mast cells in atopic dermatitisTlx3 Function in the Dorsal Root Ganglion is Pivotal to Itch and Pain Sensations.Itch mechanisms and circuits.A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airwaysAnimal models of atopic dermatitis.A mechanism for the initiation of allergen-induced T helper type 2 responsesIL-31 associated with coronary artery lesion formation in Kawasaki diseaseRetinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietinActivation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitisIL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variantsNovel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis.Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.Interleukin-31: a novel diagnostic marker of allergic diseases.Target-oriented therapy: Emerging drugs for atopic dermatitis.Interleukin-31 pathway and its role in atopic dermatitis: a systematic review.Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells.Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in miceDescending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signalingAtopic dermatitis in children: clinical features, pathophysiology, and treatment
P2860
Q24642117-66A155FF-3EF1-4CC3-9F7B-BBEEDA857DEBQ24642983-36D8FA68-1396-41A2-B225-49473A0157BEQ24648324-1B955134-7646-45BA-BF8E-B8EDA7B8D298Q26799579-B6477892-A2D2-4166-A628-941996AA8770Q26823953-356A52C1-6172-4B8B-8198-67FD6C0F480FQ26852335-1775BBD9-7867-4B52-A839-9C9DDD7B005BQ27001202-8706A720-1188-46C3-8294-8B130E06CF8EQ27001941-539F99BC-F5DF-45CF-BE2E-64B98862ED37Q27011823-03277395-B980-4DA3-889C-E5BA408975AEQ27013600-4A41BE08-65EB-47CF-B8FF-E216A9E38C1AQ27023344-2E217981-B886-4ABC-9FA3-0C7E0075C94AQ27692549-A0E373A4-FD2E-4C56-A29E-507709299E23Q27693841-00EB916F-FC67-4FDC-AB70-FA3BEBEC50F4Q28079028-172D0077-0FF5-40F0-8621-F104E7BFC5BAQ28512078-595B9762-59EB-4507-BB53-0D2D328B940DQ30428749-981757B2-411F-4D16-8898-E58165D4C872Q30834750-940BBA69-205A-4829-B61F-9C36382B4189Q33621496-76A5ADC0-7A2E-4D31-979D-0A934E5FAE35Q33721279-231A0E90-AC2B-41EF-8F3C-37E7EEB1D8D8Q33731849-04189F62-D1A7-4102-8BD5-2450A0CBCF40Q33843303-3E0C49D7-F076-4142-A5FF-2A6DAF9102E0Q33844491-6006287D-18C2-4D11-BD2C-37158759CF00Q33904280-B4FD0318-3DDB-4E0A-B87A-8BC7F68E68BBQ33904814-CA3DAB51-9CD0-4AD6-BA59-DEBE14A4A090Q33915252-AC8C6E36-F226-41E8-8477-C662B9E4927AQ34010133-37310019-3651-4D28-BD7E-89C4BD66FB82Q34047318-27736460-94CE-402E-B3FB-43167DD56013Q34078594-CF33ACE1-92FB-4DD0-9A19-48F4D48D5306Q34137362-F74813DD-82F9-4018-A16B-244B3FDAAEC5Q34320238-9F9F713A-4CDB-4F99-8FBE-008C346FE97CQ34328403-E19F2444-3F9E-406F-8A24-3F344A47629FQ34381832-5EEAEBFF-BCDC-4080-A3DD-59F2333FFBC7Q34402215-55C6DAE1-EEA2-496A-BFBB-5667BD3DEC70Q34403290-C5071F1F-C0D8-4BC8-BEE3-3484F005EA42Q34510687-3C993C75-A22C-44AF-B1BF-808003FB0B6DQ34550406-DD3BB304-EAC0-40F7-AE4A-F8F6905D3C44Q34577734-0A175E12-11EF-4E48-BF69-84614CADED41Q34619451-22A37585-EF17-4E9A-B54B-BDA0D2383784Q34625536-D7CFF0D8-C829-4542-AB11-88634015D23CQ34625597-658DDE2B-DB8C-4F03-9F5A-014DC7D351ED
P2860
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@ast
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@en
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@nl
type
label
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@ast
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@en
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@nl
prefLabel
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@ast
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@en
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@nl
P2093
P2860
P3181
P356
P1433
P1476
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
@en
P2093
Angela Hammond
Brandon Harder
Cindy Sprecher
Cosette LeCiel
Dennis L Dong
Don Foster
Francis J Grant
Harald S Haugen
Heather Day
Jane A Gross
P2860
P304
P3181
P356
10.1038/NI1084
P407
P577
2004-07-01T00:00:00Z